A 47-year-old stem cell transplant recipient with fever, cough and chest pain.

about

A 47-year-old stem cell transplant recipient with fever, cough and chest pain.

Item

http://www.wikidata.org/entity/Q40152435

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A 47-year-old stem cell transplant recipient with fever, cough and chest pain.

@en

type

Item

label

A 47-year-old stem cell transplant recipient with fever, cough and chest pain.

@en

prefLabel

A 47-year-old stem cell transplant recipient with fever, cough and chest pain.

@en

P1476

A 47-year-old stem cell transplant recipient with fever, cough and chest pain.

@en

P2093

Faisal A Khasawneh

http://www.w3.org/2001/XMLSchema#string

Omar N Nadhem

http://www.w3.org/2001/XMLSchema#string

Omar S Salh

http://www.w3.org/2001/XMLSchema#string

Ruba A Halloush

http://www.w3.org/2001/XMLSchema#string

Sanket R Thakore

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.

Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

Hodgkin lymphoma-like posttransplantation lymphoproliferative disorder.

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

Epstein-Barr virus associated post-transplant Hodgkin lymphoma in an adult patient after cord blood stem cell transplantation for acute lymphoblastic leukemia.

EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT.

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.

De novo malignances in pediatric organ transplant recipients.

P304

144-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/132162

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26057372

http://www.w3.org/2001/XMLSchema#string

P932

4470546

http://www.w3.org/2001/XMLSchema#string